Nanoviricides Inc is a development stage nano-biopharmaceutical company. Its business activities are to discover, develop and commercialize therapeutics to take care of patients suffering from life-threatening viral infections.
| Website: | www.nanoviricides.com |
| Email: | info@nanoviricides.com |
| Main Phone: | +1 203 937-6137 |
| Address: | 1 Controls Drive |
| State: | CT |
| City / Town: | Shelton |
| Country: | USA |
| Postal Code: | 6484 |
| Exchange: | AMX |
| CEO: | Eugene Seymour |
| Employees: | 7 |
| NAICS: | Pharmaceutical Preparation Manufacturing (325412) |
| Last Price 0.42 | Change $ 0.015 | Change % 3.70 | Tick N/A |
| Bid N/A | Bid Size 0.00 | Ask 0.44 | Ask Size 100.00 |
| Open 0.41 | High 0.44 | Low 0.39 | Prev Close 0.41 |
| Last Trade | Volume 132,962 | 52 Wk Hi 1.64 | 52 Wk Low 0.36 |
| Market Cap 29 mi | Ex-Div Date N/A | Div Rate N/A | Yield N/A |
| Shares 68,985,000.00 | EPS (TTM) -0.14 | PE Ratio N/A | Exchange NYSE American |
|
|
|
|
| Last 3 Mo | Last 12 Mo | |
|---|---|---|
| Number of Insider Trades | 0 | 0 |
| Number of Buys | 0 | 0 |
| Number of Sells | 0 | 0 |
| Net Activity | 0 | 0 |
| Last 10 Buys | Shares |
|---|---|
| Milton Boniuk | 1,000 |
| Milton Boniuk | 1,000 |
| Milton Boniuk | 1,000 |
| Milton Boniuk | 1,000 |
| Milton Boniuk | 1,000 |
| Milton Boniuk | 1,000 |
| Milton Boniuk | 1,000 |
| Milton Boniuk | 1,000 |
| Milton Boniuk | 1,000 |
| Milton Boniuk | 1,000 |
| Last 10 Sell | Shares |
|---|---|
| Anil Diwan | 1,000 |
| Anil Diwan | 1,000 |
| Anil Diwan | 1,000 |
| Anil Diwan | 1,000 |
| Anil Diwan | 1,000 |
| Anil Diwan | 1,000 |
| Anil Diwan | 1,000 |
| Anil Diwan | 1,000 |
| Anil Diwan | 1,000 |
| Anil Diwan | 1,000 |
| Current | 1 Week Ago | 2 Weeks Ago | 3 Weeks Ago | |
|---|---|---|---|---|
| High Target Price Estimate | 7.21 | 7.21 | 7.21 | 7.21 |
| Low Target Price Estimate | 7.21 | 7.21 | 7.21 | 7.21 |
| Mean Target Price Estimate | 7.21 | 7.21 | 7.21 | 7.21 |
| Standard Deviation | 0 | 0 | 0 | 0 |
| Date of Most Recent Estimate | 09/16/14 | 09/16/14 | 09/16/14 | 09/16/14 |
| Form Type | Form Description | Pages | Date |
|---|---|---|---|
| 10-Q | Quarterly report with a continuing view of a company's financial position | 55 | 2018-05-21 |
| NT 10-Q | Notification that form 10-Q will be submitted late | 2 | 2018-05-15 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2018-05-04 |
| 8-K | Report of unscheduled material events or corporate changes. | 24 | 2018-05-04 |
| 10-Q | Quarterly report with a continuing view of a company's financial position | 48 | 2018-02-20 |
| NT 10-Q | Notification that form 10-Q will be submitted late | 2 | 2018-02-14 |
| 8-K | Report of unscheduled material events or corporate changes. | 3 | 2017-12-15 |
| 424B5 | Prospectus filed under Rule 424(b)(5) | 29 | 2017-11-22 |
| 10-Q | Quarterly report with a continuing view of a company's financial position | 50 | 2017-11-14 |
| DEFR14A | Information for Proxy Statement under Rule 14a-101 | 35 | 2017-11-08 |
| Current | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 1 |
| Moderate Buy | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 |
| Moderate Sell | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 |
| Mean Rec. | 0 | 0 | 0 | 1 |
© 2018 Equities
* All dates and time are being displayed in Eastern Standard Time (EST).
